• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分枝杆菌中的抗菌药物耐药性:分子遗传学见解

Antimicrobial agent resistance in mycobacteria: molecular genetic insights.

作者信息

Musser J M

机构信息

Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Clin Microbiol Rev. 1995 Oct;8(4):496-514. doi: 10.1128/CMR.8.4.496.

DOI:10.1128/CMR.8.4.496
PMID:8665467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC172873/
Abstract

The primary theme emerging from molecular genetic work conducted with Mycobacterium tuberculosis and several other mycobacterial species is that resistance is commonly associated with simple nucleotide alterations in target chromosomal genes rather than with acquisition of new genetic elements encoding antibiotic-altering enzymes. Mutations in an 81-bp region of the gene (rpoB) encoding the beta subunit of RNA polymerase account for rifampin resistance in 96% of M. tuberculosis and many Mycobacterium leprae isolates. Streptomycin resistance in about one-half of M. tuberculosis isolates is associated with missense mutations in the rpsL gene coding for ribosomal protein S12 or nucleotide substitutions in the 16S rRNA gene (rrs). Mutations in the katG gene resulting in catalase-peroxidase amino acid alterations nad nucleotide substitutions in the presumed regulatory region of the inhA locus are repeatedly associated with isoniazid-resistant M. tuberculosis isolates. A majority of fluoroquinolone-resistant M. tuberculosis isolates have amino acid substitutions in a region of the DNA gyrase A subunit homologous to a conserved fluoroquinolone resistance-determining region. Multidrug-resistant isolates of M. tuberculosis arise as a consequence of sequential accumulation of mutations conferring resistance to single therapeutic agents. Molecular strategies show considerable promise for rapid detection of mutations associated with antimicrobial resistance. These approaches are now amenable to utilization in an appropriately equipped clinical microbiology laboratory.

摘要

对结核分枝杆菌和其他几种分枝杆菌进行分子遗传学研究得出的主要结论是,耐药性通常与靶染色体基因中的简单核苷酸改变有关,而不是与获得编码抗生素改变酶的新遗传元件有关。编码RNA聚合酶β亚基的基因(rpoB)中一个81bp区域的突变,在96%的结核分枝杆菌和许多麻风分枝杆菌分离株中导致利福平耐药。约一半的结核分枝杆菌分离株对链霉素耐药与编码核糖体蛋白S12的rpsL基因中的错义突变或16S rRNA基因(rrs)中的核苷酸替换有关。katG基因的突变导致过氧化氢酶-过氧化物酶氨基酸改变以及inhA基因座假定调控区域中的核苷酸替换,这与耐异烟肼的结核分枝杆菌分离株反复相关。大多数耐氟喹诺酮的结核分枝杆菌分离株在DNA旋转酶A亚基的一个区域中存在氨基酸替换,该区域与一个保守的氟喹诺酮耐药决定区域同源。耐多药的结核分枝杆菌分离株是由于赋予对单一治疗药物耐药性的突变的顺序积累而产生的。分子策略在快速检测与抗菌药物耐药性相关的突变方面显示出很大的前景。这些方法现在适合在配备适当的临床微生物学实验室中使用。

相似文献

1
Antimicrobial agent resistance in mycobacteria: molecular genetic insights.分枝杆菌中的抗菌药物耐药性:分子遗传学见解
Clin Microbiol Rev. 1995 Oct;8(4):496-514. doi: 10.1128/CMR.8.4.496.
2
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.结核分枝杆菌抗微生物剂耐药性的分子遗传学基础:1998年更新版
Tuber Lung Dis. 1998;79(1):3-29. doi: 10.1054/tuld.1998.0002.
3
Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.结核分枝杆菌临床分离株耐药性的分子机制
Chin Med J (Engl). 1999 Jun;112(6):524-8.
4
Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.通过自动DNA测序对结核分枝杆菌异烟肼耐药和敏感菌株中过氧化氢酶-过氧化物酶基因(katG)和inhA基因座的特征分析:与耐药相关的有限突变阵列
J Infect Dis. 1996 Jan;173(1):196-202. doi: 10.1093/infdis/173.1.196.
5
Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis.结核分枝杆菌临床分离株中多药耐药的分子机制
J Infect Dis. 1995 Apr;171(4):954-60. doi: 10.1093/infdis/171.4.954.
6
[Mechanisms of drug-resistance in mycobacteria].[分枝杆菌的耐药机制]
Nihon Rinsho. 1998 Dec;56(12):3023-9.
7
[Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance].[耐多药结核病。2. 结核分枝杆菌耐药机制——耐药的遗传机制]
Kekkaku. 1998 Nov;73(11):657-63.
8
Streptomycin resistance in mycobacteria.分枝杆菌中的链霉素耐药性。
Antimicrob Agents Chemother. 1994 Feb;38(2):238-42. doi: 10.1128/AAC.38.2.238.
9
Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.检测耐多药结核分枝杆菌临床分离株中与异烟肼耐药相关的突变。
J Antimicrob Chemother. 2014 Sep;69(9):2369-75. doi: 10.1093/jac/dku161. Epub 2014 May 22.
10
[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].[评估基因型MTBDR检测法在临床结核分枝杆菌复合群临床分离株中快速检测利福平及异烟肼耐药性的效果]
Mikrobiyol Bul. 2009 Apr;43(2):217-26.

引用本文的文献

1
Sentinel-Site-Based Surveillance of Drug Resistance and Epidemiology in Sichuan, China.中国四川基于哨点的耐药性与流行病学监测
Antibiotics (Basel). 2025 Jun 20;14(7):625. doi: 10.3390/antibiotics14070625.
2
Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China.采用全基因组测序分析中国赣州耐多药结核分枝杆菌的传播特征。
BMC Infect Dis. 2025 Jul 28;25(1):950. doi: 10.1186/s12879-025-11356-w.
3
Diverse impacts of different rpoB mutations on the anti-tuberculosis efficacy of capreomycin.不同rpoB基因突变对卷曲霉素抗结核疗效的多样影响。
EBioMedicine. 2025 May 30;117:105776. doi: 10.1016/j.ebiom.2025.105776.
4
Direct detection from sputum for drug-resistant Mycobacterium tuberculosis using a CRISPR-Cas14a-based approach.使用基于CRISPR-Cas14a的方法直接从痰液中检测耐多药结核分枝杆菌。
BMC Microbiol. 2025 Apr 2;25(1):188. doi: 10.1186/s12866-025-03899-4.
5
Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China.2019 年至 2021 年中国四川耐多药或利福平耐药结核分枝杆菌的耐药特征、遗传多样性和传播动态。
Antimicrob Resist Infect Control. 2024 Oct 14;13(1):125. doi: 10.1186/s13756-024-01482-6.
6
Genome sequences of sp. Elmwood and accompanying phage, isolated from a public swimming pool in Nebraska.从内布拉斯加州一个公共游泳池分离出的埃尔姆伍德菌及伴随噬菌体的基因组序列。
Microbiol Resour Announc. 2024 Nov 12;13(11):e0089624. doi: 10.1128/mra.00896-24. Epub 2024 Sep 30.
7
Legionella pneumophila exploits the endo-lysosomal network for phagosome biogenesis by co-opting SUMOylated Rab7.嗜肺军团菌通过共招 SUMO 化 Rab7 来利用内体溶酶体网络进行吞噬体生物发生。
PLoS Pathog. 2024 May 13;20(5):e1011783. doi: 10.1371/journal.ppat.1011783. eCollection 2024 May.
8
Differences in Physiological Performance and Gut Microbiota between Deep-Sea and Coastal Aquaculture of Thachinotus Ovatus: A Metagenomic Approach.卵形鲳鲹深海与沿海养殖的生理性能及肠道微生物群差异:宏基因组学方法
Animals (Basel). 2023 Oct 30;13(21):3365. doi: 10.3390/ani13213365.
9
Integrating Molecular Diagnostics and GIS Mapping: A Multidisciplinary Approach to Understanding Tuberculosis Disease Dynamics in South Africa Using Xpert MTB/RIF.整合分子诊断与地理信息系统绘图:一种运用Xpert MTB/RIF了解南非结核病疾病动态的多学科方法。
Diagnostics (Basel). 2023 Oct 10;13(20):3163. doi: 10.3390/diagnostics13203163.
10
Molecular Characteristics and Prevalence of Rifampin Resistance in Isolates from Patients with Bacteremia in South Korea.韩国菌血症患者分离株中利福平耐药的分子特征及流行情况
Antibiotics (Basel). 2023 Oct 4;12(10):1511. doi: 10.3390/antibiotics12101511.

本文引用的文献

1
A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli.南印度结核杆菌与英国结核杆菌对豚鼠毒力的比较。
Tubercle. 1960 Feb;41:1-22. doi: 10.1016/s0041-3879(60)80019-0.
2
EFFECT OF ETHAMBUTOL ON NUCLEIC ACID METABOLISM IN MYCOBACTERIUM SMEGMATIS AND ITS REVERSAL BY POLYAMINES AND DIVALENT CATIONS.乙胺丁醇对耻垢分枝杆菌核酸代谢的影响及其被多胺和二价阳离子逆转的作用
J Bacteriol. 1965 May;89(5):1299-305. doi: 10.1128/jb.89.5.1299-1305.1965.
3
A COMPARATIVE STUDY OF THE SUSCEPTIBILITY TO ETHIONAMIDE, THIOSEMICARBAZONE, AND ISONIAZID OF TUBERCLE BACILLI FROM PATIENTS NEVER TREATED WITH ETHIONAMIDE OR THIOSEMICARBAZONE.从未接受过乙硫异烟胺或硫脲类药物治疗的患者结核杆菌对乙硫异烟胺、硫脲类药物和异烟肼敏感性的比较研究
Am Rev Respir Dis. 1964 Sep;90:468-9. doi: 10.1164/arrd.1964.90.3.468.
4
Mode of action of ethambutol.乙胺丁醇的作用方式。
J Bacteriol. 1962 Nov;84(5):1099-103. doi: 10.1128/jb.84.5.1099-1103.1962.
5
A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol).一种在小鼠中具有抗结核活性的新型合成化合物:乙胺丁醇(右旋-2,2'-(乙二胺基)-二-1-丁醇)。
Am Rev Respir Dis. 1961 Jun;83:891-3. doi: 10.1164/arrd.1961.83.6.891.
6
Ethionamide.乙硫异烟胺
Br Med J. 1960 Oct 22;2(5207):1207-8. doi: 10.1136/bmj.2.5207.1207.
7
Relation of pyrogallol-peroxidative activity to isoniazid resistance in Mycobacterium tuberculosis.结核分枝杆菌中连苯三酚过氧化物酶活性与异烟肼耐药性的关系
Am Rev Tuberc. 1957 Apr;75(4):670-4. doi: 10.1164/artpd.1957.75.4.670.
8
Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients.异烟肼与结核杆菌的研究。III. 来自接受异烟肼治疗患者的结核杆菌的分离、药敏性及过氧化氢酶检测
Am Rev Tuberc. 1954 Nov;70(5):852-72. doi: 10.1164/art.1954.70.5.852.
9
Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants.异烟肼与结核杆菌的研究。II. 异烟肼耐药突变体的生长需求、过氧化氢酶活性及致病特性
Am Rev Tuberc. 1954 Oct;70(4):641-64. doi: 10.1164/art.1954.70.4.641.
10
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.结核杆菌的异烟肼耐药性与过氧化氢酶活性;初步报告。
Am Rev Tuberc. 1954 Mar;69(3):471-2. doi: 10.1164/art.1954.69.3.471.